The cancer diagnostics technology developer, formed five years ago when Qiagen acquired part of Enzymatics, has filed to float on the Nasdaq Global Market.

Varian Medical Systems and Johnson & Johnson Innovation – JJDC returned for the series C-1 round having backed the histotripsy technology developer's series C last year.

McMaster University spinout Fusion Pharmaceuticals has filed for a $100m IPO in the US, putting shareholders such as Facit in line for exits.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The hearing loss treatment developer has filed to raise up to $100m, three months after a $105m round featuring Novartis, Partners HealthCare and Pivotal BioVenture Partners.

Caisse de dépôt et placement du Québec has become the second Canadian limited partner to join Theodorus’ fourth fund, which now stands at $47.3m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Sunshine Insurance participated in a $70.7m round for the contract biopharmaceutical services provider that follows $59m last year.

The advanced body scanner developer has boosted the SK Telecom, Foxconn and Fujifilm-backed round to $51m and is now valued at about $600m.

DocsApp, whose investors include DeNA and Techmatrix, has joined forces with MediBuddy in deal buoyed by a $20m round backed by Mitsui Sumitomo.